フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
LILLY (ELI) & COMPANY - 4th Quarter Earnings PR Newswire London, January 30 Date: January 30, 2014 For Release: Immediately Refer to: (317...
LILLY (ELI) & COMPANY - Half-yearly Report PR Newswire London, July 24 Date: July 24, 2013 For Release: Immediately Refer to: (317) 276-5795...
LILLY (ELI) & COMPANY - Form 8-K PR Newswire London, July 8 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________...
LILLY (ELI) & COMPANY - Doc re Form 8K Filing PR Newswire London, May 8 Company Lilly (Eli) & Co. TIDM LEL Headline Doc re Form 8-K...
LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgery PR Newswire London, May 7 Date: May 6, 2013 For Release: Immediately Refer to:...
LILLY (ELI) & COMPANY - 1st Quarter Results PR Newswire London, May 2 Company Lilly (Eli) & Co. TIDM LEL Headline 1st Quarter...
LILLY (ELI) & COMPANY - Doc re Form 8-K Filing PR Newswire London, April 24 Company Lilly (Eli) & Co. TIDM LEL Headline Doc re Form 8-K...
Company Lilly (Eli) & Co. TIDM LEL Headline Further re: Cancellation of Listing CANCELLATION OF LISTING OF SHARES Eli Lilly and Company hereby...
LILLY (ELI) & COMPANY - Cancellation of Listing PR Newswire London, March 28 Company Lilly (Eli) & Co. TIDM LEL Headline Further re:...
Official List 28 March 2013 NOTICE OF CANCELLATION OF LISTING FROM THE OFFICIAL LIST 28/03/2013 8:00 am CANCELLATION LILLY (ELI) & COMPANY The...
LILLY (ELI) & COMPANY - Doc re Proxy Statements PR Newswire London, March 26 Company Lilly (Eli) & Co. TIDM LEL Headline Doc re Proxy...
LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of Shares PR Newswire London, March 26 Company Lilly (Eli) & Co. TIDM...
LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing PR Newswire London, February 27 Company Lilly (Eli) & Co. TIDM...
LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for Tabalumab LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約